Pharmacokinetics of a losartan transdermal system in healthy men

Pharmacokinetics of a losartan transdermal system in healthy men - Pharmacokinetics of a losartan transdermal system in healthy men

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016116

Enrollment

Registered

2015-01-06

Start date

2015-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Transdermal formulation for losartan potassium Placebo (Transdermal formulation for Placebo)

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy men aged 20-40 years old

Exclusion criteria

Exclusion criteria: (1) Inability to obtain informed consent (2) Participant with diseases under treatment (3) Drug allergy (4) Inappropriate participants due to other reasons

Design outcomes

Primary

Measure	Time frame
Pharmacokinetics of losartan and its active metabolite EXP-3174	—

Secondary

Measure	Time frame
Safety and tolerability	—

Countries

Japan

Contacts

Public ContactKeiichi Odagiri

Hamamatsu University School of Medicine Department of Clinical Pharmacology & Therapeutics

kodagiri@hama-med.ac.jp053-435-2385

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026